.5M) in mid-to-late-stage life sciences targeting high-burden infectious diseases, sexual/reproductive health, and maternal/child health in low- and middle-income countries [1][2]. Her distinctive thesis fills a capital gap for affordable drugs, vaccines, diagnostics, and devices addressing neglected diseases like…
- Stages: Early Stage Venture, Late Stage Venture, Venture
- Focus: Financial Services, Health Care, Venture Capital, Biotechnoplogy, Health Care, Medical, Life Science, Manufacturing, Biopharma, Therapeutics, Medical Device, Genetics, Health Diagnostics, Early Stage Venture, Late Stage Venture, Venture
- Location: New York, NY
Website
Browse all investors · Browse founders
